Bacterial vaginosis

2 trials 2 recruiting MedDRA PT
2 Registered trials
2 Recruiting
2 Unique sponsors
5 Unique IMPs
2 Commercial trials
Drug classes (ATC)
D Dermatology (ATC D) 1
P Parasitology (ATC P) 1
G Urology/Gynaecology (ATC G) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Azole antifungal 1 substance
Macrolide / aminoglycoside 1 substance
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Adamed Pharma S.A. Commercial
    CLINDAMYCIN PHOSPHATE; FURAZIDINE
    2024-515332-80-00 4 countries 2026 n=600
    Recruiting

Phase II

1 trial
  • Freya Biosciences ApS Commercial
    CHLORHEXIDINE GLUCONATE; FRE01, FRE02, FRE04, FRE03; METRONIDAZOLE
    2025-524362-20-00 1 country 2026 n=120
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Freya Biosciences ApS Commercial 1 Phase II 1
Adamed Pharma S.A. Commercial 1 Phase III 1
New trials by year
2026
2
← All indication landscapes